Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 23, Issue 34
December 1, 2005
 

Down EDITORIALS
Down ORIGINAL REPORTS
  Down Treatment-Related Complications
  Down Breast Cancer
  Down Head And Neck Cancer
  Down Head and Neck Cancer
  Down Melanoma
  Down Gastrointestinal Cancer
  Down Genitourinary Cancer
  Down Clinical Trials
  Down Radiation Oncology
  Down Lung Cancer
  Down Gynecologic Cancer
  Down Genetic Testing for Cancer
  Down Pediatric Oncology
  Down Immunotherapy
  Down Sarcomas
  Down Neurooncology
  Down Cost Effectiveness
  Down Clinical Practice
Down REVIEW ARTICLE
Down DIAGNOSIS IN ONCOLOGY
Down ART OF ONCOLOGY
Down CORRESPONDENCE
Down ERRATUM

Find articles in this issue containing these words:
[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
EDITORIALS Back
The Irreversibility of Radiation-Induced Fibrosis: Fact or Folklore?
Mitchell S. Anscher
JCO Dec 1 2005: 8551–8552. First published on Oct 31 2005; 10.1200/JCO.2005.03.6194. [Full Text] [PDF]  
Can Statin Therapy Reduce the Risk of Breast Cancer?
Victor G. Vogel
JCO Dec 1 2005: 8553–8555. First published on Oct 31 2005; 10.1200/JCO.2005.03.6202. [Full Text] [PDF]  
Induction Redux: Once More With Taxanes
David J. Adelstein
JCO Dec 1 2005: 8556–8558. First published on Nov 7 2005; 10.1200/JCO.2005.03.6145. [Full Text] [PDF]  
Building Upon the Standard of Care in Adjuvant Therapy of High-Risk Melanoma
John M. Kirkwood
JCO Dec 1 2005: 8559–8563. First published on Oct 31 2005; 10.1200/JCO.2005.01.8168. [Full Text] [PDF]  
Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: A Commentary
Judith Abrams
JCO Dec 1 2005: 8564–8565. First published on Oct 31 2005; 10.1200/JCO.2005.03.6186. [Full Text] [PDF]  
Carboplatin for Stage I Seminoma and the Sword of Damocles
Patrick J. Loehrer, Sr and George J. Bosl
JCO Dec 1 2005: 8566–8569. First published on Oct 31 2005; 10.1200/JCO.2005.03.0361. [Full Text] [PDF]  
 
ORIGINAL REPORTS Back

Treatment-Related Complications Back

Kinetics of Response to Long-Term Treatment Combining Pentoxifylline and Tocopherol in Patients With Superficial Radiation-Induced Fibrosis
  Sylvie Delanian, Raphaël Porcher, Jérémie Rudant, and Jean-Louis Lefaix
  JCO Dec 1 2005: 8570–8579. First published on Oct 31 2005; 10.1200/JCO.2005.02.4729. [Abstract] [Full Text] [PDF]  
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
  Aristotle Bamias, Efstathios Kastritis, Christina Bamia, Lia A. Moulopoulos, Ioannis Melakopoulos, George Bozas, Vassiliki Koutsoukou, Dimitra Gika, Athanasios Anagnostopoulos, Christos Papadimitriou, Evagelos Terpos, and Meletios A. Dimopoulos
  JCO Dec 1 2005: 8580–8587. [Abstract] [Full Text] [PDF]  
Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Development
  Kristin R. Gilmer Knight, Dale F. Kraemer, and Edward A. Neuwelt
  JCO Dec 1 2005: 8588–8596. [Abstract] [Full Text] [PDF]  
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
  John J. Doyle, Alfred I. Neugut, Judith S. Jacobson, Victor R. Grann, and Dawn L. Hershman
  JCO Dec 1 2005: 8597–8605. [Abstract] [Full Text] [PDF]  

Breast Cancer Back

Use of Statins and Breast Cancer: A Meta-Analysis of Seven Randomized Clinical Trials and Nine Observational Studies
  Stefanos Bonovas, Kalitsa Filioussi, Nikolaos Tsavaris, and Nikolaos M. Sitaras
  JCO Dec 1 2005: 8606–8612. First published on Oct 31 2005; 10.1200/JCO.2005.02.7045. [Abstract] [Full Text] [PDF]  
Allele Imbalance, or Loss of Heterozygosity, in Normal Breast Epithelium of Sporadic Breast Cancer Cases and BRCA1 Gene Mutation Carriers Is Increased Compared With Reduction Mammoplasty Tissues
  Pamela S. Larson, Benjamin L. Schlechter, Antonio de las Morenas, Judy E. Garber, L. Adrienne Cupples, and Carol L. Rosenberg
  JCO Dec 1 2005: 8613–8619. [Abstract] [Full Text] [PDF]  
Temporal and Geographic Variation in the Use of Hematopoietic Growth Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings From a Large Population-Based Cohort
  Xianglin L. Du, David R. Lairson, Charles E. Begley, and Shenying Fang
  JCO Dec 1 2005: 8620–8628. [Abstract] [Full Text] [PDF]  
Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers
  Joan L. Kramer, Isela A. Velazquez, Bingshu E. Chen, Philip S. Rosenberg, Jeffery P. Struewing, and Mark H. Greene
  JCO Dec 1 2005: 8629–8635. [Abstract] [Full Text] [PDF]  

Head And Neck Cancer Back

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
  Ricardo Hitt, Antonio López-Pousa, Javier Martínez-Trufero, Vicente Escrig, Joan Carles, Alfredo Rizo, Dolores Isla, M. Eugenia Vega, Juan L. Martí, Francisco Lobo, Pedro Pastor, Vicente Valentí, Joaquín Belón, Miguel A. Sánchez, Carlos Chaib, Cinta Pallarés, Antonio Antón, Andrés Cervantes, Luis Paz-Ares, and Hernán Cortés-Funes
  JCO Dec 1 2005: 8636–8645. First published on Nov 7 2005; 10.1200/JCO.2004.00.1990. [Abstract] [Full Text] [PDF] [Publisher's Note]  

Head and Neck Cancer Back

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study
  Barbara Burtness, Meredith A. Goldwasser, William Flood, Bassam Mattar, and Arlene A. Forastiere
  JCO Dec 1 2005: 8646–8654. [Abstract] [Full Text] [PDF] [Publisher's Note]  

Melanoma Back

Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial Comparing Adjuvant Interferon Alfa and Isotretinoin With Interferon Alfa Alone in Stage IIA and IIB Melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group
  Erika Richtig, H. Peter Soyer, Martin Posch, Ulrike Mossbacher, Peter Bauer, Ligia Teban, Gerhard Svolba, Ingrid H. Wolf, Peter Fritsch, Bernhard Zelger, Beatrix Volc-Platzer, Walter Gebhart, Paul Mischer, Andreas Steiner, Wolf Pachinger, Helmut Hintner, Friedrich Gschnait, Klemens Rappersberger, Peter Pilarski, and Hubert Pehamberger
  JCO Dec 1 2005: 8655–8663. First published on Oct 31 2005; 10.1200/JCO.2004.00.8128. [Abstract] [Full Text] [PDF]  

Gastrointestinal Cancer Back

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials
  Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller, Richard Gray, Jacqueline K. Benedetti, Marc Buyse, Roberto Labianca, Jean Francois Seitz, Christopher J. O'Callaghan, Guido Francini, Axel Grothey, Michael O'Connell, Paul J. Catalano, Charles D. Blanke, David Kerr, Erin Green, Norman Wolmark, Thierry Andre, Richard M. Goldberg, and Aimery De Gramont
  JCO Dec 1 2005: 8664–8670. First published on Oct 31 2005; 10.1200/JCO.2005.01.6071. [Abstract] [Full Text] [PDF]  
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089
  Daniel G. Haller, Paul J. Catalano, John S. Macdonald, Mark A. O'Rourke, Michael S. Frontiera, Don V. Jackson, and Robert J. Mayer
  JCO Dec 1 2005: 8671–8678. [Abstract] [Full Text] [PDF]  
Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome
  M. Wasif Saif, Mohammaed A. Eloubeidi, Suzanne Russo, Adam Steg, Jennifer Thornton, John Fiveash, Mark Carpenter, Carmello Blanquicett, Robert B. Diasio, and Martin R. Johnson
  JCO Dec 1 2005: 8679–8687. [Abstract] [Full Text] [PDF]  
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
  Claus Rödel, Peter Martus, Thomas Papadoupolos, Laszlo Füzesi, Martin Klimpfinger, Rainer Fietkau, Torsten Liersch, Werner Hohenberger, Rudolf Raab, Rolf Sauer, and Christian Wittekind
  JCO Dec 1 2005: 8688–8696. First published on Oct 24 2005; 10.1200/JCO.2005.02.1329. [Abstract] [Full Text] [PDF]  
Adverse Effects of Preoperative Radiation Therapy for Rectal Cancer: Long-Term Follow-Up of the Swedish Rectal Cancer Trial
  Helgi Birgisson, Lars Påhlman, Ulf Gunnarsson, and Bengt Glimelius
  JCO Dec 1 2005: 8697–8705. [Abstract] [Full Text] [PDF]  
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
  Adam C. Berger, Elin R. Sigurdson, Thomas LeVoyer, Alexandra Hanlon, Robert J. Mayer, John S. Macdonald, Paul J. Catalano, and Daniel G. Haller
  JCO Dec 1 2005: 8706–8712. [Abstract] [Full Text] [PDF]  
Recent Chemotherapy Reduces the Sensitivity of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Detection of Colorectal Metastases
  Timothy Akhurst, Tara J. Kates, Madhu Mazumdar, Henry Yeung, Elyn R. Riedel, Bryan M. Burt, Leslie Blumgart, William Jarnagin, Steven M. Larson, and Yuman Fong
  JCO Dec 1 2005: 8713–8716. [Abstract] [Full Text] [PDF]  

Genitourinary Cancer Back

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study
  Jorge Aparicio, José R. Germà, Xavier García del Muro, Pablo Maroto, José A. Arranz, Alberto Sáenz, Agustín Barnadas, Joan Dorca, Josep Gumà, David Olmos, Romá Bastús, Joan Carles, Daniel Almenar, Miguel Sánchez, Luis Paz-Ares, Juan J. Satrústegui, Begoña Mellado, Ana Balil, Marta López-Brea, and Alfredo Sánchez
  JCO Dec 1 2005: 8717–8723. First published on Oct 31 2005; 10.1200/JCO.2005.01.9810. [Abstract] [Full Text] [PDF]  
Ixabepilone (Epothilone B Analogue BMS-247550) Is Active in Chemotherapy-Naive Patients With Hormone-Refractory Prostate Cancer: A Southwest Oncology Group Trial S0111
  Maha Hussain, Catherine M. Tangen, Primo N. Lara, Jr, Ulka N. Vaishampayan, Daniel P. Petrylak, A. Dimitrios Colevas, Wael A. Sakr, and E. David Crawford
  JCO Dec 1 2005: 8724–8729. [Abstract] [Full Text] [PDF]  

Clinical Trials Back

Factors Affecting Older African American Women's Decisions to Join the PLCO Cancer Screening Trial
  Jeanette M. Trauth, Jan C. Jernigan, Laura A. Siminoff, Donald Musa, Derietra Neal-Ferguson, and Joel Weissfeld
  JCO Dec 1 2005: 8730–8738. [Abstract] [Full Text] [PDF]  

Radiation Oncology Back

Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic Malignancies
  Edgar Ben-Josef, Daniel Normolle, William D. Ensminger, Suzette Walker, Daniel Tatro, Randall K. Ten Haken, James Knol, Laura A. Dawson, Charlie Pan, and Theodore S. Lawrence
  JCO Dec 1 2005: 8739–8747. [Abstract] [Full Text] [PDF]  
Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation Pneumonitis
  Dominique Arpin, David Perol, Jean-Yves Blay, Lionel Falchero, Line Claude, Sylvie Vuillermoz-Blas, Isabelle Martel-Lafay, Chantal Ginestet, Laurent Alberti, Dimitri Nosov, Bénédicte Etienne-Mastroianni, Vincent Cottin, Maurice Perol, Jean-Claude Guerin, Jean-François Cordier, and Christian Carrie
  JCO Dec 1 2005: 8748–8756. [Abstract] [Full Text] [PDF]  

Lung Cancer Back

Bexarotene and Erlotinib for Aerodigestive Tract Cancer
  Konstantin H. Dragnev, W. Jeffrey Petty, Sumit Shah, Adrian Biddle, Neil B. Desai, Vincent Memoli, James R. Rigas, and Ethan Dmitrovsky
  JCO Dec 1 2005: 8757–8764. [Abstract] [Full Text] [PDF]  
Wnt5a Expression Is Associated With the Tumor Proliferation and the Stromal Vascular Endothelial Growth Factor—An Expression in Non–Small-Cell Lung Cancer
  Cheng-long Huang, Dage Liu, Jun Nakano, Shinya Ishikawa, Keiichi Kontani, Hiroyasu Yokomise, and Masaki Ueno
  JCO Dec 1 2005: 8765–8773. [Abstract] [Full Text] [PDF]  
Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFR{alpha}, PDGFRß, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung
  Giulio Rossi, Alberto Cavazza, Alessandro Marchioni, Lucia Longo, Mario Migaldi, Giuliana Sartori, Nazzarena Bigiani, Laura Schirosi, Christian Casali, Uliano Morandi, Nicola Facciolongo, Antonio Maiorana, Mario Bavieri, Leonardo M. Fabbri, and Elisabeth Brambilla
  JCO Dec 1 2005: 8774–8785. [Abstract] [Full Text] [PDF]  
Multicenter Phase I/II Study of Cetuximab With Paclitaxel and Carboplatin in Untreated Patients With Stage IV Non–Small-Cell Lung Cancer
  Christiane D. Thienelt, Paul A. Bunn, Jr, Nasser Hanna, Arthur Rosenberg, Michael N. Needle, Michael E. Long, Daniel L. Gustafson, and Karen Kelly
  JCO Dec 1 2005: 8786–8793. First published on Oct 24 2005; 10.1200/JCO.2005.03.1997. [Abstract] [Full Text] [PDF]  

Gynecologic Cancer Back

Logistic Regression Model to Distinguish Between the Benign and Malignant Adnexal Mass Before Surgery: A Multicenter Study by the International Ovarian Tumor Analysis Group
  Dirk Timmerman, Antonia C. Testa, Tom Bourne, Enrico Ferrazzi, Lieveke Ameye, Maja L. Konstantinovic, Ben Van Calster, William P. Collins, Ignace Vergote, Sabine Van Huffel, and Lil Valentin
  JCO Dec 1 2005: 8794–8801. [Abstract] [Full Text] [PDF]  
Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial
  Simon C. Crawford, Paul A. Vasey, Jim Paul, Andrea Hay, Jo A. Davis, and Stan B. Kaye
  JCO Dec 1 2005: 8802–8811. [Abstract] [Full Text] [PDF] [Publisher's Note]  

Genetic Testing for Cancer Back

Genetic Testing in Pheochromocytoma or Functional Paraganglioma
  Laurence Amar, Jérôme Bertherat, Eric Baudin, Christiane Ajzenberg, Brigitte Bressac-de Paillerets, Olivier Chabre, Bernard Chamontin, Brigitte Delemer, Sophie Giraud, Arnaud Murat, Patricia Niccoli-Sire, Stéphane Richard, Vincent Rohmer, Jean-Louis Sadoul, Laurence Strompf, Martin Schlumberger, Xavier Bertagna, Pierre-François Plouin, Xavier Jeunemaitre, and Anne-Paule Gimenez-Roqueplo
  JCO Dec 1 2005: 8812–8818. [Abstract] [Full Text] [PDF]  

Pediatric Oncology Back

Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy
  Rochelle Bagatell, Pavlina Rumcheva, Wendy B. London, Susan L. Cohn, A. Thomas Look, Garrett M. Brodeur, Christopher Frantz, Vijay Joshi, Paul Thorner, P.V. Rao, Robert Castleberry, and Laura C. Bowman
  JCO Dec 1 2005: 8819–8827. [Abstract] [Full Text] [PDF]  
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
  Douglas S. Hawkins, Scott M. Schuetze, James E. Butrynski, Joseph G. Rajendran, Cheryl B. Vernon, Ernest U. Conrad, III, and Janet F. Eary
  JCO Dec 1 2005: 8828–8834. [Abstract] [Full Text] [PDF]  

Immunotherapy Back

Phase I Study of the Sequential Combination of Interleukin-12 and Interferon Alfa-2b in Advanced Cancer: Evidence for Modulation of Interferon Signaling Pathways by Interleukin-12
  Charles F. Eisenbeis, Gregory B. Lesinski, Mirela Anghelina, Robin Parihar, Daniel Valentino, Jing Liu, Padma Nadella, Poongothai Sundaram, Donn C. Young, Mario Sznol, Michael J. Walker, and William E. Carson, III
  JCO Dec 1 2005: 8835–8844. [Abstract] [Full Text] [PDF]  

Sarcomas Back

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups
  Stefano Ferrari, Sigbjorn Smeland, Mario Mercuri, Franco Bertoni, Alessandra Longhi, Pietro Ruggieri, Thor A. Alvegard, Piero Picci, Rodolfo Capanna, Gabriella Bernini, Cristoph Müller, Amelia Tienghi, Thomas Wiebe, Alessandro Comandone, Tom Böhling, Adalberto Brach Del Prever, Otte Brosjö, Gaetano Bacci, and Gunnar Sæter
  JCO Dec 1 2005: 8845–8852. First published on Oct 24 2005; 10.1200/JCO.2004.00.5785. [Abstract] [Full Text] [PDF]  

Neurooncology Back

Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma
  Frank Mendrzyk, Bernhard Radlwimmer, Stefan Joos, Felix Kokocinski, Axel Benner, Daniel E. Stange, Kai Neben, Heike Fiegler, Nigel P. Carter, Guido Reifenberger, Andrey Korshunov, and Peter Lichter
  JCO Dec 1 2005: 8853–8862. [Abstract] [Full Text] [PDF]  
Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution
  Stephanie E. Combs, Christoph Thilmann, Lutz Edler, Jürgen Debus, and Daniela Schulz-Ertner
  JCO Dec 1 2005: 8863–8869. [Abstract] [Full Text] [PDF]  
Phase II Trial of Radiosurgery for One to Three Newly Diagnosed Brain Metastases From Renal Cell Carcinoma, Melanoma, and Sarcoma: An Eastern Cooperative Oncology Group Study (E 6397)
  Rafael Manon, Anne O'Neill, Jonathan Knisely, Maria Werner-Wasik, Hillard M. Lazarus, Henry Wagner, Mark Gilbert, and Minesh Mehta
  JCO Dec 1 2005: 8870–8876. [Abstract] [Full Text] [PDF]  

Cost Effectiveness Back

Costs and Cost Effectiveness of a Health Care Provider–Directed Intervention to Promote Colorectal Cancer Screening Among Veterans
  Michael S. Wolf, Karen A. Fitzner, Eowyn F. Powell, Kathryn R. McCaffrey, A. Simon Pickard, June M. McKoy, Julia Lindenberg, Glen T. Schumock, Kenneth R. Carson, M. Rosario Ferreira, Nancy C. Dolan, and Charles L. Bennett
  JCO Dec 1 2005: 8877–8883. [Abstract] [Full Text] [PDF]  

Clinical Practice Back

Health Behaviors of Cancer Survivors: Examining Opportunities for Cancer Control Intervention
  Keith M. Bellizzi, Julia H. Rowland, Diana D. Jeffery, and Timothy McNeel
  JCO Dec 1 2005: 8884–8893. [Abstract] [Full Text] [PDF]  
 
REVIEW ARTICLE Back
Caveat Medicus: Consequences of Federal Investigations of Marketing Activities of Pharmaceutical Suppliers of Prostate Cancer Drugs
  June M. McKoy, E. Allison Lyons, Eniola Obadina, Kenneth Carson, A. Simon Pickard, Paul Schellhammer, David McLeod, Cynthia E. Boyd, Norene McWilliams, Oliver Sartor, Glen T. Schumock, Kathryn McCaffery, and Charles L. Bennett
  JCO Dec 1 2005: 8894–8905. [Abstract] [Full Text] [PDF]  
 
DIAGNOSIS IN ONCOLOGY Back
Positive Positron Emission Tomography Scan in Sarcoidosis and Two Challenging Cases of Metastatic Cancer: CASE 1. Mediastinal Sarcoidosis in a Melanoma Patient Treated With Interferon
Baudewijn W. Hendrickx, Carla M.L. van Herpen, Johannes J. Bonenkamp, Johannes Bulten, and Wim J.G. Oyen
JCO Dec 1 2005: 8906–8907. [Full Text] [PDF]  
Positive Positron Emission Tomography Scan in Sarcoidosis and Two Challenging Cases of Metastatic Cancer: CASE 2. Hepatocellular Carcinoma With Metastasis to the Breast
Ji-Young Rhee, Joon Oh Park, Ghee Young Kwon, SeokJin Nam, Byung Chul Yoo, Young Suk Park, Young-hyuk Im, Won Ki Kang, and Keunchil Park
JCO Dec 1 2005: 8908–8909. [Full Text] [PDF]  
Positive Positron Emission Tomography Scan in Sarcoidosis and Two Challenging Cases of Metastatic Cancer: CASE 3. Hoarseness Caused by Cancer Metastasis to the Vagus Nerve
Thomas Weber, Beatrix Hoksch, Meike Körner, Freimut Jüngling, and Ralph A. Schmid
JCO Dec 1 2005: 8909–8910. [Full Text] [PDF]  
 
ART OF ONCOLOGY Back
A Bayesian Approach to a Patient With a Residual Mass After Treatment for Non-Hodgkin's Lymphoma of the Thyroid
John Bibb, Robert Hromas, and Ian Rabinowitz
JCO Dec 1 2005: 8911–8913. [Full Text] [PDF]  
 
CORRESPONDENCE Back
Radiotherapy and Hodgkin's Lymphoma
Prajnan Das, Chul S. Ha, and James D. Cox
JCO Dec 1 2005: 8914–8915. [Full Text] [PDF]  
In Reply:
Ralph M. Meyer, Mary K. Gospodarowicz, Joseph M. Connors, Robert G. Pearcey, and Lois E. Shepherd
JCO Dec 1 2005: 8915–8916. [Full Text] [PDF]  
Heparanase Activity and Bone Loss in Postmenopausal Breast Cancer Patients
Kadri Altundag, Ozden Altundag, Mauricio Z. Baptista, and Serap Akyurek
JCO Dec 1 2005: 8916–8917. [Full Text] [PDF]  
In Reply:
Per Eystein Lønning and Jurgen Geisler
JCO Dec 1 2005: 8917–8918. [Full Text] [PDF]  
Can the Reliance of Hormone Receptor Assays of Surgical Specimens Be Explained by the Fluctuation of Estrogen Receptor, Progesterone Receptor, and HER-2 Protein Expression in Tumor Samples of Premenopausal Breast Cancer Patients?
Andrea Alimonti, Gianluigi Ferretti, and Francesco Cognetti
JCO Dec 1 2005: 8918. [Full Text] [PDF]  
In Reply:
G. Bruce Mann and Malcolm R. Buchanan
JCO Dec 1 2005: 8918-a–8919. [Full Text] [PDF]  
Circulating MYCN DNA Predicts MYCN-Amplification in Neuroblastoma
Valérie Combaret, Christophe Bergeron, Rosa Noguera, Isabelle Iacono, and Alain Puisieux
JCO Dec 1 2005: 8919–8920. [Full Text] [PDF]  
In Reply:
Takahiro Gotoh, Hajime Hosoi, Tomoko Iehara, Kunihiko Tsuchiya, Tohru Sugimoto, and Akira Nakagawara
JCO Dec 1 2005: 8920. [Full Text] [PDF]  
 
ERRATUM Back
ERRATUM
JCO Dec 1 2005: 8921. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online